Oxytocin-receptor agonist nonapeptide
Oxytocin
Gq-coupled OXTR causing uterine contraction and milk ejection; central social-salience signalling is additional neurobiology.
Primary Mechanism of Action
Clinical / Scientific
Oxytocin binds OXTR (Gq), raising intracellular calcium in myometrium and myoepithelial cells. Central oxytocin circuits modulate social salience. Pharmaceutical oxytocin is established in obstetrics; research acetate salts are the same peptide hormone.
Pathway Targets
Oxytocin receptor
Scientific explanation
Gq-Ca2+ agonism in uterus, breast, and CNS circuits.
Pathway Convergence
Clinical / Scientific
Target → pathway → downstream effect → biological consequence. This is a mechanistic map, not a treatment claim.
Receptor to physiology
Target to downstream effect: Oxytocin receptor
Mechanistically Relevant Repurposed & Adjunctive Applications
Labour induction / postpartum haemorrhage / lactation (labelled oxytocin)
EstablishedMechanistic rationale
Established obstetric peptide. Dosing and route are highly protocol-bound.
Mechanistic Application Matrix
| Biological Target | Mechanism | Potential Relevance | Evidence Level |
|---|---|---|---|
| OXTR | Agonism | Myometrial contraction / milk ejection | Established mechanism |
Mechanistic Interaction Considerations
Potentiation of other uterotonics; cardiovascular effects. Not a casual “bonding” dose recommendation.
In Plain Language
Oxytocin is the hormone that contracts the uterus and ejects milk. The same system in the brain is involved in social signalling.
Mechanistic information is provided for scientific and educational purposes. Discussion of biological pathways or investigational applications does not establish clinical efficacy or constitute individualized medical advice.